Smoking and myelodysplastic syndromes

Area of Science:

• Hematology
• Environmental Health
• Genetics

Background:

• Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
• The etiology of MDS is largely unknown, but environmental factors are suspected.
• Tobacco smoking is a common environmental exposure with known links to various cancers.

Purpose of the Study:

• To investigate tobacco smoking as a risk factor for myelodysplastic syndromes (MDS).
• To explore the association between smoking and specific morphological subtypes and karyotypic aberrations in MDS.
• To assess the relationship between smoking exposure (intensity, duration) and MDS risk.

Main Methods:

• A case-control study design was employed.
• 330 adult MDS cases and 337 matched controls were interviewed for smoking history.
• Smoking history was collected, including duration and time relative to diagnosis.

Main Results:

• Smoking for at least 1 year, 20 years or less before diagnosis, was associated with an elevated relative risk (OR 1.8) for primary MDS.
• Risk correlated with smoking intensity and duration.
• Smoking showed a significant association with MDS involving chromosome 7 abnormalities (OR 5.0).
• Elevated risks were observed for refractory anemia (OR 2.5) and refractory anemia with ringed sideroblasts (OR 3.2).

Conclusions:

• Tobacco smoking is a significant risk factor for developing myelodysplastic syndromes.
• Specific MDS subtypes and chromosomal abnormalities, like those involving chromosome 7, are particularly associated with smoking.
• Smoking cessation may reduce the risk of MDS, with risk decreasing after a few years post-cessation.